Company / Financials
Gilead Sciences Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$29.4B
FY2025 · +2.4% YoY
Net Income
$8.5B
FY2025 · +1672.9% YoY
Profit Margin
28.9%
FY2025 · net income / revenue
ROE
37.5%
FY2025 · return on equity
Total Assets
$59.0B
FY2025
Total Debt
$24.9B
1.10x debt/equity
Equity
$22.7B
FY2025
ROA
14.4%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$29.4B+2.4% YoYNet Income HistoryProfit after all expenses and taxes$8.5B+1672.9% YoYGross Profit HistoryRevenue minus cost of goods sold$4.2BCost of Revenue HistoryDirect costs of producing goods and services sold$6.2B-0.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes$10.0B+503.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$5.8B-5.2% YoYR&D Expense HistoryResearch and development spending$5.8B-1.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.0BIncome Tax HistoryTotal income tax expense$1.3B+509.5% YoYEPS (Basic) HistoryBasic earnings per share$4.54+24.0% YoY